Procalcitonin test availability: A survey of acute care hospitals in Massachusetts

Annals of the American Thoracic Society

Volumn 14, Issue 9, 2017, Pages 1489-1491

  Fisher, Kimberly A ^a,b   Landyn, Valentina ^b   Lindenauer, Peter K ^a,c   Walkey, Allan J ^d  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c University of Massachusetts Medical School   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROCALCITONIN;

CLINICAL PRACTICE; EMERGENCY CARE; FUNCTION TEST; HEALTH CARE AVAILABILITY; HEALTH CARE SYSTEM; HOSPITAL; HUMAN; LABORATORY TEST; LETTER; MASSACHUSETTS; MULTIHOSPITAL SYSTEM; PATIENT TRANSPORT; PROCALCITONIN TEST; TURNAROUND TIME; ACUTE DISEASE; HEALTH CARE SURVEY; HOSPITAL MANAGEMENT; STATISTICS AND NUMERICAL DATA;

ACUTE DISEASE; HEALTH CARE SURVEYS; HOSPITALS; HUMANS; INVENTORIES, HOSPITAL; MASSACHUSETTS; PROCALCITONIN;

EID: 85029381232     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201704-306RL     Document Type: Letter

References (13)

1. Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, Srinivasan A, Dellit TH, Falck-Ytter YT, Fishman NO, et al. Implementing an antibiotic stewardship program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Nephrol Dial Transplant 2016;62:e77.
2. National action plan for combating antibiotic-resistant bacteria. 2015 [accessed 2017 Mar 20] Available from: Https://obamawhitehouse. archives.gov/sites/default/files/docs/national-action-plan-for-combating- antibotic-resistant-bacteria.pdf
3. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-518.
4. Kip MM, Kusters R, IJzerman MJ, Steuten LM. A PCT algorithm for discontinuation of antibiotic therapy is a cost-effective way to reduce antibiotic exposure in adult intensive care patients with sepsis. J Med Econ 2015;18:944-953.
5. Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, Neidert S, Fricker T, Blum C, Schild U, et al.; ProHOSP Study Group. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: The ProHOSP randomized controlled trial. JAMA 2009;302:1059-1066.
6. Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, et al.; PRORATA trial group. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): A multicentre randomised controlled trial. Lancet 2010;375:463-474.
7. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Müller B. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: Cluster-randomised, single-blinded intervention trial. Lancet 2004; 363:600-607.
8. Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: A randomized trial. Am J Respir Crit Care Med 2008;177: 498-505.
9. HochreiterM, Köhler T, Schweiger AM, Keck FS, Bein B, von Spiegel T, Schroeder S. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: A randomized prospective controlled trial. Crit Care 2009;13:R83.
10. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, et al. Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016. Crit Care Med 2017;45:486-552.
11. Soni NJ, Samson DJ, Galaydick JL, Vats V, Huang ES, Aronson N, Pitrak DL. Procalcitonin-guided antibiotic therapy: A systematic review and meta-analysis. J Hosp Med 2013;8:530-540.
12. Chu DC, Mehta AB, Walkey AJ. Practice patterns and outcomes associated with procalcitonin use in critically ill patients with sepsis. Clin Infect Dis 2017;64:1509-1515.
13. Balk RA, Kadri SS, Cao Z, Robinson SB, Lipkin C, Bozzette SA. Effect of procalcitonin testing on health-care utilization and costs in critically ill patients in the united states. Chest 2017; 151:23-33.